Literature DB >> 8706234

A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995.

J Y Riou1, S Djibo, L Sangare, J P Lombart, P Fagot, J P Chippaux, M Guibourdenche.   

Abstract

Between 14 January and 4 April 1995 we isolated and characterized 44 meningococcal strains in Cameroon, Chad, Niger, and Burkina Faso; among these was the strain A:4:P1.9/clone III-1, which was involved in the second meningitis pandemic. This isolate was found in the clonal form in Niger and strains of the ET-37 complex were also found in the other three study countries, but apparently did not cause epidemics. One strain (Y:2a:P1.2,5 (ET-37 complex)) was isolated in January 1995 and another (A:4:P1.9) in March 1995 in Garoua (Cameroon). Eight strains were isolated in Moundou (Chad) between January and April 1995: the A:4:P1.9/clone III-1 (1 strain); members of the ET-37 complex (Y:2a:P1.2,5 (4 strains), Y:NT:P1.2,5 (1 strain), and Y:2a:-(1 strain)); and serogroup X (1 strain). In Niger, 31 strains were isolated between February and April 1995 from different regions. All were A:4:P1.9/clone III-1; between November 1994 and April 1995 there were 23814 cases of meningitis reported of which 2227 resulted in death. Three strains were isolated in Burkina Faso in April 1995: two were Y:2a:P1.2,5 (ET-37 complex) and one was A:4:P1.9/clone III-1. Thus in 1995 the epidemic and invasive strain (A:4:P1.9/clone III-1) responsible for the second pandemic was present in the four countries (Cameroon, Chad, Niger and Burkino Faso) that make up the area frequently affected by such epidemics and where cases are generally reported during the dry season.

Entities:  

Mesh:

Year:  1996        PMID: 8706234      PMCID: PMC2486908     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  18 in total

Review 1.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

2.  Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis.

Authors:  G Morelli; J del Valle; C J Lammel; J Pohlner; K Müller; M Blake; G F Brooks; T F Meyer; B Koumaré; N Brieske
Journal:  Mol Microbiol       Date:  1994-01       Impact factor: 3.501

3.  [Transport medium for meningococci].

Authors:  M Vandekerkove; P Bradstreet; R Faucon; S Benech
Journal:  Ann Inst Pasteur (Paris)       Date:  1967-08

Review 4.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

5.  Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis.

Authors:  J F Wang; D A Caugant; G Morelli; B Koumaré; M Achtman
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

6.  The worldwide prevention of meningococcal infection. Still an elusive goal.

Authors:  L H Harrison
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

7.  Group A meningococcal disease in England associated with the Haj.

Authors:  D M Jones; E M Sutcliffe
Journal:  J Infect       Date:  1990-07       Impact factor: 6.072

8.  Genetic relationships and clonal population structure of serotype 2 strains of Neisseria meningitidis.

Authors:  D A Caugant; W D Zollinger; L F Mocca; C E Frasch; T S Whittam; L O Frøholm; R K Selander
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

9.  Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.

Authors:  F E Ashton; J A Ryan; A Borczyk; D A Caugant; L Mancino; D Huang
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  Characteristics of serogroup A Neisseria meningitidis strains isolated in the Central African Republic in February 1992.

Authors:  M Guibourdenche; D A Caugant; V Hervé; J M Debonne; C Lanckriet; M Merlin; C Mathiot; J B Roungou; G Martet; J Y Riou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

View more
  10 in total

1.  Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.

Authors:  Yih-Ling Tzeng; Corie Noble; David S Stephens
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Genetic analysis of a meningococcal population based on polymorphism of the pilA-pilB locus: a molecular approach for meningococcal epidemiology.

Authors:  M Guibourdenche; D Giorgini; A Guèye; M Larribe; J Y Riou; M K Taha
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Capsule switching of Neisseria meningitidis.

Authors:  J S Swartley; A A Marfin; S Edupuganti; L J Liu; P Cieslak; B Perkins; J D Wenger; D S Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 4.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

5.  Clonal groupings in serogroup X Neisseria meningitidis.

Authors:  Sébastien Gagneux; Thierry Wirth; Abraham Hodgson; Ingrid Ehrhard; Giovanna Morelli; Paula Kriz; Blaise Genton; Tom Smith; Fred Binka; Gerd Pluschke; Mark Achtman
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

6.  Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.

Authors:  Dominique A Caugant; Paul A Kristiansen; Xin Wang; Leonard W Mayer; Muhamed-Kheir Taha; Rasmata Ouédraogo; Denis Kandolo; Flabou Bougoudogo; Samba Sow; Laurence Bonte
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Epidemic meningococcal meningitis, Cameroon.

Authors:  D Massenet; D Vohod; H Hamadicko; D A Caugant
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

8.  Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.

Authors:  Dean B Everett; Mavuto Mukaka; Brigitte Denis; Stephen B Gordon; Enitan D Carrol; Joep J van Oosterhout; Elizabeth M Molyneux; Malcolm Molyneux; Neil French; Robert S Heyderman
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

9.  Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008.

Authors:  Denis Massenet; Jermias Inrombe; Dave Etienne Mevoula; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Authors:  D M Daugla; J P Gami; K Gamougam; N Naibei; L Mbainadji; M Narbé; J Toralta; B Kodbesse; C Ngadoua; M E Coldiron; F Fermon; A-L Page; M H Djingarey; S Hugonnet; O B Harrison; L S Rebbetts; Y Tekletsion; E R Watkins; D Hill; D A Caugant; D Chandramohan; M Hassan-King; O Manigart; M Nascimento; A Woukeu; C Trotter; J M Stuart; McJ Maiden; B M Greenwood
Journal:  Lancet       Date:  2013-09-12       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.